Mayo Clinic recently completed a four-year review of Myasthenia Gravis serum evaluations and will be implementing changes to our testing algorithm.
Effective January 26, 2021, the reference range for the Gestational Diabetes 1 Hour Screen will be updated from 65-140 to 65-135. This reference range adjustment is being made to better align with the current practices of our OB/GYN providers for abnormal flagging for gestational diabetes.
In an effort to streamline laboratory processes and provide expedited results, the test Herpes Simplex 1 / 2 IGG IGM was replaced with Herpes Simplex Panel on July 17, 2019. The new panel will still offer both Herpes IgM and Herpes IgG. The conversion to this panel will allow the lab to report Herpes IgG results faster.